Organic Cation Transporter 2 Controls Brain Norepinephrine and Serotonin Clearance and Antidepressant Response
Total Page:16
File Type:pdf, Size:1020Kb
Molecular Psychiatry (2012) 17, 926–939 & 2012 Macmillan Publishers Limited All rights reserved 1359-4184/12 www.nature.com/mp ORIGINAL ARTICLE Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response A Bacq1,2,3, L Balasse1,2,3, G Biala4, B Guiard5, AM Gardier5, A Schinkel6, F Louis1,2,3, V Vialou1,2,3,9, M-P Martres1,2,3, C Chevarin3,7, M Hamon3,7, B Giros1,2,3,8 and S Gautron1,2,3 1INSERM U952, Paris, France; 2CNRS UMR 7224, Paris, France; 3UPMC University Paris 06, Paris, France; 4Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, Lublin, Poland; 5Laboratoire de Neuropharmacologie EA3544, Universite´ Paris-Sud XI, Faculte´ de Pharmacie, Chaˆtenay-Malabry, France; 6Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; 7INSERM UMR 677, Faculte´ de Me´decine Pierre et Marie Curie, Site Pitie´-Salpeˆtrie`re, IFR 70 des Neurosciences, Paris, France and 8Douglas Hospital, Department of Psychiatry, McGill University, Montreal, QC, Canada High-affinity transporters for norepinephrine (NE) and serotonin (5-HT), which ensure neurotransmitter clearance at the synapse, are the principal targets of widely used antidepressant drugs. Antidepressants targeting these high-affinity transporters, however, do not provide positive treatment outcomes for all patients. Other monoamine transport systems, with lower affinity, have been detected in the brain, but their role is largely unknown. Here we report that OCT2, a member of the polyspecific organic cation transporter (OCT) family, is expressed notably in the limbic system and implicated in anxiety and depression- related behaviors in the mouse. Genetic deletion of OCT2 in mice produced a significant reduction in brain tissue concentrations of NE and 5-HT and in ex vivo uptake of both these neurotransmitters in the presence of the dual 5-HT–NE transport blocker, venlafaxine. In vivo clearance of NE and 5-HT evaluated using microiontophoretic electrophysiology was diminished in the hippocampus of OCT2À/À mice in the presence of venlafaxine, thereby affecting postsynaptic neuronal activity. OCT2À/À mice displayed an altered sensitivity to acute treatments with NE- and/or 5-HT-selective transport blockers in the forced-swim test. Moreover, the mutant mice were insensitive to long-term venlafaxine treatment in a more realistic, corticosterone-induced, chronic depression model. Our findings identify OCT2 as an important postsynaptic determinant of aminergic tonus and mood-related behaviors and a potential pharmacological target for mood disorders therapy. Molecular Psychiatry (2012) 17, 926–939; doi:10.1038/mp.2011.87; published online 19 July 2011 Keywords: aminergic neurotransmission; antidepressant response; depression; mood; organic cation transporter Introduction various psychoactive compounds including some of the classical antidepressants, which potently inhibit Neurotransmitter transporters exert a crucial role in the serotonin (SERT) and/or norepinephrine (NET) the control of synaptic transmission by ensuring the transporters.1,2 This notion has been for decades a rapid clearance of the released transmitters from the compelling argument in support of the ‘monoamine’ synaptic cleft and their recycling into the nerve hypothesis of depression, which assumes that endings. In monoaminergic pathways, this clearance hypoactivity of 5-HT and NE pathways occurs during is carried out principally by high-affinity sodium- depression that can be counterbalanced by anti- driven transporters for dopamine (DA), 5-HT and depressant treatment.3 Central serotonergic and nor- norepinephrine (NE), embedded in the plasma mem- adrenergic pathways control a wide range of func- brane of the presynaptic terminal. These high-affinity tions including mood and emotion, and dysfunction reuptake transporters are the primary target for of these circuits has indeed been implicated in the etiology and physiopathology of anxiety and Correspondence: Dr S Gautron, UMRS952/UMR7224, UPMC, 9 depression.4 Quai St Bernard, 75252 Paris Cedex 05, France. Although the critical role of the high-affinity E-mail: [email protected] transporters in monoamine clearance and antidepres- 9 Present address: Fishberg Department of Neuroscience, Mount sant action is firmly established, it has been suspected Sinai School of Medicine, New York, NY 10029, USA. Received 25 January 2011; revised 10 June 2011; accepted 13 June for years that additional monoamine clearance sys- 2011; published online 19 July 2011 tems may exist in the brain. Low-affinity monoamine Role of OCT2 in monoamine clearance and antidepressant response A Bacq et al 927 uptake through non-cognate transporters has been Immunohistochemistry and immunoautoradiography suggested in earlier studies using transport, voltam- Free-floating immunohistochemistry was performed metry or microdialysis approaches, and selective as detailed in Supplementary Material and Methods. blockers and mouse mutants for the high-affinity For immunoautoradiography, kidney or brain cryo- transporters.5–7 The rigorous interpretation of these sections were fixed with 4% paraformaldehyde/PBS studies has been confounded, however, by the limited and incubated successively with OCT2 (1/500), OCT3 knowledge concerning the specificity of the inhibitors (1/500)9 or PMAT antibodies raised against peptide used as pharmacological tools. Thus, the physiologi- sequence YLHHKYPGTSIVF (1/500; Agro-Bio, La Ferte´ cal function of these low-affinity uptake components St Aubin, France), and with [125I] anti-rabbit IgGs (Perkin in central nervous system has remained elusive. Elmer, Boston, MA, USA) and exposed to film for 3–8 Potential candidates that could ensure low-affinity days. Analysis and quantification of autoradiograms monoamine transport in the brain include the organic were carried out with MCID software (Imaging Research, cation transporter (OCT) family8–10 and the plasma Brock University, St Catherines, Ontario, Canada). membrane monoamine transporter (PMAT),11 all of which have the capacity to transport aminergic Monoamine uptake neurotransmitters in vitro. OCTs have been investi- Mice were killed by decapitation and the hippocam- gated principally for their role in the handling of pus and frontal cortex were dissected, minced on ice organic cations in peripheral organs,12,13 and are and resuspended in ice-cold sucrose (0.32 M). The currently emerging as novel but ill-characterized cells were dissociated by filtering through nylon components of aminergic neurotransmission. Mice meshes of decreasing pore size (180–60 mm, Small deficient for OCT3 show changes in the neural and Parts, Miramar, FL, USA) and resuspended in ice-cold behavioral responses to environmentally induced sucrose. The cellular suspension was preincubated variations in osmolarity, altered monoamine neuro- 10 min at 37 1C in 3 vol of Krebs Ringer Hepes LiCl transmission in the brain and increased sensitivity to buffer (25 mM HEPES–KOH, pH 7.4, 125 mM LiCl, 9,14 psychostimulants, suggesting a ‘back-up’ role in 4.8 mM KCl, 5.6 mM D( þ )-glucose, 1.2 mM CaCl2, monoamine clearance, supported by studies of mice 1.2 mM KH2PO4 and 1.2 mM MgSO4) in the presence lacking SERT.15 OCT3 was also shown to have an of 5 mM venlafaxine (Tocris Bioscience, Bristol, UK), important role in 1-methyl-4-phenyl-1,2,3,6-tetrahy- 100 mM GBR12935, 10 mM pargyline and 10 mM reser- dropyridine-induced neurodegeneration in dopami- pine (Sigma-Aldrich, St Louis, MO, USA), and nergic pathways, by allowing the release of the incubated for 15 min at 37 1C in the same buffer neurotoxic derivative MPP þ in the extracellular supplemented with 10 mM [3H] NE, [3H] 5-HT, [3H] DA space.16 or [3H] glutamate (Perkin Elmer). The effect of OCT2 is another member of the OCT family, which citalopram on endogenous OCT2 activity was was detected previously in the brain.10,17 On the basis evaluated in the presence of increasing concentra- of its ability to transport 5-HT and NE, we hypo- tions of this antidepressant (0.1–10 mM) during pre- thesized that this transporter could modulate mono- incubation and uptake. The reaction was terminated aminergic neurotransmission in complement to the by rapid filtration through Unifilter-96 GF/C filters high-affinity transporters, and have a role in the (Perkin Elmer), and after washing the radioactivity control of mood and related functions. To test this retained on the filters was assessed by liquid possibility, we investigated the contribution of OCT2 scintillation. The protein concentration in tissue to monoamine clearance in vivo in the brain and its extracts was measured by Bradford’s method. OCT- functional consequences on postsynaptic neuronal mediated uptake was quantified by inhibition with activity, as well as on anxiety and depression-related the specific inhibitor decynium 22 (D22) (1,10-diethyl- behaviors and the response to antidepressants. 2,20-cyanine iodide)18 (500 mM; Sigma-Aldrich). Data are expressed as mean±s.e.m. of D22-sensitive uptake for 4–6 independent experiments performed in triplicate. Materials and methods Determination of monoamine brain content Animals Brain structures were assessed for monoamine and OCT2À/À mice were previously generated by homo- metabolite content by high-performance liquid chro- logous recombination.13 Heterozygous animals with matography as previously reported.19 10 backcross generations into C57BL6/J were bred to generate wild-type and knockout littermates, which